Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
US12338247B2 · kind B2 · utility
0Cited by
3References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 31, 2022 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Mar 31, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.